Medicina

Medicine & Life Sciences

1. 10-valent pneumococcal conjugate vaccine 10%
2. Acute Kidney Injury 7%
3. acylaminoacyl-peptidase 9%
4. Adult Respiratory Distress Syndrome 8%
5. Antidepressive Agents 9%
6. Astrocytes 12%
7. Autoimmune Experimental Encephalomyelitis 7%
8. Biomarkers 15%
9. Bipolar Disorder 43%
10. Blood Vessels 7%
11. Brain 7%
12. Case-Control Studies 7%
13. Cell- and Tissue-Based Therapy 25%
14. Child 13%
15. Chile 73%
16. Chronic Renal Insufficiency 6%
17. Cohort Studies 8%
18. Cold Temperature 7%
19. Communicable Diseases 8%
20. Confidence Intervals 6%
21. Conjugate Vaccines 8%
22. Coronavirus 12%
23. Cost-Benefit Analysis 6%
24. Dental Pulp 6%
25. Depression 7%
26. Exosomes 36%
27. Extracellular Vesicles 38%
28. Fetal Growth Retardation 13%
29. Fetus 6%
30. First Pregnancy Trimester 10%
31. Fluoxetine 13%
32. Gestational Age 7%
33. Gestational Diabetes 16%
34. Gingival Crevicular Fluid 14%
35. Health 12%
36. Hypertension 7%
37. Hypoxia 6%
38. Immunization 8%
39. Immunization Programs 9%
40. Immunosuppressive Agents 11%
41. In Vitro Techniques 8%
42. Incidence 7%
43. Infections 6%
44. Inflammation 7%
45. Kainic Acid 7%
46. Kidney 15%
47. Latin America 13%
48. Macrophages 10%
49. Meningococcal Infections 15%
50. Mesenchymal Stem Cells 100%
51. Meta-Analysis 9%
52. MicroRNAs 16%
53. Mitochondria 12%
54. Mortality 17%
55. Mothers 19%
56. N-Methyl-D-Aspartate Receptors 7%
57. Neisseria meningitidis 7%
58. Neural Stem Cells 7%
59. Neurogenesis 7%
60. Neuronal Plasticity 8%
61. Neurons 10%
62. Neuropilin-1 12%
63. NFATC Transcription Factors 7%
64. Obesity 9%
65. Periodontitis 12%
66. Peritoneal Dialysis 10%
67. Peroxisome Proliferator-Activated Receptors 11%
68. Phenotype 13%
69. Placenta 10%
70. Pneumococcal Infections 12%
71. Pneumococcal Vaccines 10%
72. Pneumonia 7%
73. Population 10%
74. Post-Synaptic Density 21%
75. Pre-Eclampsia 26%
76. Pregnancy 29%
77. Pregnant Women 13%
78. Prosencephalon 7%
79. Proteins 13%
80. Randomized Controlled Trials 7%
81. Regeneration 12%
82. Regenerative Endodontics 7%
83. Regulatory T-Lymphocytes 17%
84. Renal Dialysis 11%
85. Rheumatoid Arthritis 11%
86. Safety 9%
87. SARS Virus 11%
88. Seizures 10%
89. Serogroup 21%
90. Spironolactone 8%
91. Stem Cells 29%
92. Synapses 7%
93. Systemic Lupus Erythematosus 11%
94. T-Lymphocytes 16%
95. Th17 Cells 15%
96. Therapeutics 17%
97. Transplantation Tolerance 7%
98. Umbilical Cord 8%
99. Vaccination 18%
100. Vaccines 21%